The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 02, 2021

Filed:

May. 01, 2017
Applicant:

The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);

Inventors:

Jonathan Tsai, Saratoga, CA (US);

Nathaniel Fernhoff, Stanford, CA (US);

Rahul Sinha, Los Altos, CA (US);

Yuval Rinkevich, Munich, DE;

Irving L. Weissman, Stanford, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 38/17 (2006.01); A61P 41/00 (2006.01); A61K 39/00 (2006.01); A61K 45/00 (2006.01); A61K 38/05 (2006.01); A61K 38/16 (2006.01); A61K 31/198 (2006.01); A61K 31/343 (2006.01); A61K 31/473 (2006.01); A61K 31/7004 (2006.01); A61K 49/00 (2006.01); C07K 16/30 (2006.01); A61K 45/06 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); A61K 38/177 (2013.01); A61K 38/1764 (2013.01); A61K 39/001168 (2018.08); A61P 41/00 (2018.01); A61K 31/198 (2013.01); A61K 31/343 (2013.01); A61K 31/473 (2013.01); A61K 31/7004 (2013.01); A61K 38/00 (2013.01); A61K 38/05 (2013.01); A61K 38/164 (2013.01); A61K 45/00 (2013.01); A61K 45/06 (2013.01); A61K 49/0002 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); C07K 16/30 (2013.01); C07K 2317/76 (2013.01);
Abstract

Aspects of the present disclosure include methods of treating a subject to reduce adhesion formation, the method comprising administering to a subject in need of thereof an agent that that targets adhesion-formation by injured mesothelial cells. The agent can act at a variety of checkpoints in the development of adhesions by injured mesothelial cells, including: targeting the injured mesothelial cells for destruction, recruiting inflammatory macrophages to the site of adhesion, preventing neutrophil recruitment to the site of adhesion, and/or inhibiting the expression or activity of a gene product whose expression is induced in the injured mesothelial cells. Compositions and kits for performing the methods are also provided.


Find Patent Forward Citations

Loading…